Acquisition and administration costs for medications used to treat rheumatoid arthritis.
tx.cost
A list with two elements: cost
and lookup
. The element
cost
is a data table of variables needed to calculate acquisition and
administration costs. Each row denotes a unique treatment. There are 17 variables:
Long-form name of treatment.
Short-form name of treatment.
FDA approved dosage.
Strength and dosage form of treatment
Numeric value of dose approved by FDA during the first 6 months of treatment.
Numeric value of dose approved by FDA beyond the first 6 months.
Unit of FDA approved dose.
Number of doses based on FDA used during the first 6 months.
Annual number of doses based on FDA beyond the first 6 months.
Numeric value of strength of treatment.
Unit of treatment.
Price per unit of treatment. By default, wholesale acquisition costs (WACs) are used.
Discounts and rebates negotiated with manufacturers typically decrease
prices paid by patients. Specificy a lower bound for this discount as a proportion of
price_per_unit
.
An upper bound for the discount as a proportion of
price_per_unit
.
Cost per infusion.
Equal to 1 if a loading dose is used and 0 otherwise. If a loading dose is used, then the infusion cost is only applied to the first dose.
If weight_based
is equal to 1, then dosing is based on each
patient's weight (i.e., as sampled by sample_pop).
The element lookup
is a data table with 3 variables. The first variable, sname
,
is the short-form name of a treatment (e.g., corresponding to sname
in
iviRA::treatments
). All remaining columns are the unique agents making up a given
treatment. For example, abatecept IV + methotrexate consists of abatecept IV and
methotrexate.